Rankings
▼
Calendar
PHIO Q3 2018 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$57,000
Gross Profit
-$781,000
-1370.2% margin
Operating Income
-$1M
-2617.5% margin
Net Income
-$1M
-2619.3% margin
EPS (Diluted)
$-2030.87
QoQ Revenue Growth
-1.7%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$39,000
Balance Sheet
Total Assets
$4M
Total Liabilities
$2M
Stockholders' Equity
$2M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$57,000
$0
—
Gross Profit
-$781,000
-$1M
+47.6%
Operating Income
-$1M
-$2M
+39.7%
Net Income
-$1M
-$2M
+39.7%
← FY 2018
All Quarters
Q4 2018 →